Immuron Limited (AU:IMC) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Immuron Limited’s CEO Steven Lydeamore is set to present at Peak Asset Management’s Peak Sky High event in Melbourne, showcasing the company’s advancements in orally delivered targeted polyclonal antibodies for infectious diseases. The presentation will include information on their flagship product, Travelan®, which is designed to prevent travelers’ diarrhea and is available in various forms across Australia, Canada, and the U.S. The company’s proprietary technology enables the creation of treatments for a range of infectious diseases, leveraging hyper-immune bovine colostrum.
For further insights into AU:IMC stock, check out TipRanks’ Stock Analysis page.